Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered With Rabies Vaccine

NCT05453487 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
Rabies

Interventions

BIOLOGICAL: coadministration
BIOLOGICAL: COVID-19 vaccine
BIOLOGICAL: rabies vaccine

Sponsor

China National Biotec Group Company Limited

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]